[193 Pages Report] The Food Allergy Diagnostics & Therapeutics Market size was estimated at USD 5.86 billion in 2023 and expected to reach USD 6.43 billion in 2024, at a CAGR 10.35% to reach USD 11.69 billion by 2030.
Food allergy diagnostics & therapeutics include drugs, therapies, and diagnostics that reduce the symptoms of food allergies and help the immune system prepare for future encounters. The rising prevalence of food allergies worldwide is driving the usage of food allergy diagnostics & therapeutics. Symptoms associated with the food allergic response could range from itchiness, swelling of the tongue, or hives to low blood pressure, diarrhea, or vomiting. The common food allergens are eggs, milk, wheat, fish, and tree nuts. In addition, technological advancements and an increase in the number of R&D initiatives being undertaken to develop drugs with higher efficacy are expected to create opportunities for the growth of the food allergy diagnostics & therapeutics market. However, the high cost associated with food allergy diagnostics & treatments makes them unaffordable for people in low-income countries.
The Americas represents a highly developing landscape for the food allergy diagnostics & therapeutics market characterized by the rising development of new diagnostic methods and an increasing number of people suffering from food allergies. According to Food Allergy Research & Education (FARE) data from 2021, one in ten adults and one in 13 children have different food allergies in America. Similarly, 32 million people in the United States have food allergies, and some common food allergens include milk, egg, peanut, tree nuts, wheat, soy, fish, and crustacean shellfish are common in the United States. The market innovators in the region are expanding their R&D activities to increase the development of new and advanced food allergy diagnostic tests. In August 2022, Eurofins Craft Technologies developed a new method to quantify different phenolic acids in foods and supplements. Phenolics are present in fruits, vegetables, grains, oils, and drinks such as coffee, tea, and wine. The increasing number of food testing labs in India, Australia, China, and Japan is expected to expand the scope of the food allergy diagnostic and therapeutics market in Asia-Pacific. In September 2021, SGS SA launched the Advance Center of Testing (ACT) at its Ambattur, Chennai, India laboratory premises, and the ACT provides fast and precise services to the agriculture and food industries.
The market dynamics represent an ever-changing landscape of the Food Allergy Diagnostics & Therapeutics Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
- Market Drivers
- Growing incidences of allergic conditions among pediatric and adult populations
- Increasing funds by organizations in food allergy diagnostics
- Rising patient demand for in vitro diagnostic blood tests
- Market Restraints
- Limited awareness and less implementation of food allergic testing methods
- Market Opportunities
- Ongoing technological advancements in food allergy diagnostics and therapeutics
- Increasing number of research and development initiatives for the development of drugs
- Market Challenges
- Stringent regulatory framework for food allergy diagnostics and therapeutics
The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Food Allergy Diagnostics & Therapeutics Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Food Allergy Diagnostics & Therapeutics Market.
The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Food Allergy Diagnostics & Therapeutics Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.
The value chain of the Food Allergy Diagnostics & Therapeutics Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.
The pricing analysis comprehensively evaluates how a product or service is priced within the Food Allergy Diagnostics & Therapeutics Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Food Allergy Diagnostics & Therapeutics Market.
The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Food Allergy Diagnostics & Therapeutics Market.
The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Food Allergy Diagnostics & Therapeutics Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.
The trade analysis of the Food Allergy Diagnostics & Therapeutics Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.
The regulatory framework analysis for the Food Allergy Diagnostics & Therapeutics Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Food Allergy Diagnostics & Therapeutics Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Food Allergy Diagnostics & Therapeutics Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Aleph Farms Increases Production Capabilities With VBL Therapeutics Facility Acquisition And ESCO Aster Partnership
Aleph Farms is setting the pace for food allergy diagnostics and therapeutics with the acquisition of VBL Therapeutics' facility and the partnership with Esco Aster. With expertise at the cutting edge of cell-based agricultural science, Aleph Farms is building a comprehensive supply chain that includes everything from origin to final delivery of its products by leveraging best-in-class partnerships. As consumer demand for allergen-free foods continues to rise, this preeminent organization is committed to delivering high quality, faithful alternatives. Aleph Farms’ progress highlights both their ambition and industry confidence in their ability to meet consumer needs with innovation and integrity. [Published On: 2023-03-01]
Jerath Path Labs expands the reach in India in allergy-testing
With the market for food allergy diagnostics and therapeutics rapidly expanding, Jerath Path Labs is well-placed to benefit from opportunities this growth presents. Their recent expansion of testing capabilities in India demonstrates their commitment to become a leading provider of allergy testing in the country. Now customers have increased access to quality tests that are cost effective and convenient as they are now offered both at large urban hospitals and in small rural health centers. Jerath Path Labs has demonstrated responsible growth with their careful consideration of the environments they operate in, ensuring reliable results no matter where the test is undertaken. This news is certainly good news for health care providers and patients alike, who will benefit from the improved accessibility of quality allergy testing. [Published On: 2023-01-23]
Deeside firm secures US patent for food allergy diagnostics
Reacta Inc. is leading the way in food allergy diagnostics and therapeutics with the recent granting of an exclusive U.S. patent for their technology by the United States Patent and Trademark Office (USPTO). This technology, a rapid test to detect specific food allergies, provides users with detailed information on their food sensitivity as well as a guide to proper dietary management. Reacta's mission is to reduce the chances of severe allergic reactions or avoid them entirely by providing targeted, actionable information to those affected. With this new patent, evidenced-based research and development are now possible enabling more accuracy in the diagnosis process for individuals living with food allergies. Ultimately, this breakthrough will ensure that millions of individuals who suffer from food allergies can live without fear of potential anaphylactic shock. [Published On: 2022-08-22]
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Food Allergy Diagnostics & Therapeutics Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
The report delves into recent significant developments in the Food Allergy Diagnostics & Therapeutics Market, highlighting leading vendors and their innovative profiles. These include 7 Drops Diagnostics, Inc., ACON Laboratories, Inc., AESKU.GROUP GmbH, ALK-Abelló A/S, Allergy Therapeutics PLC, Alpha Laboratories, Apexhealth by Acecgt Diagnostic Limited, Apollo Diagnostics, Aster Clinical Lab LLP, Astra Biotech GmbH, bioMérieux SA, Cerascreen GmbH, Eurofins Scientific (Ireland) Limited, EUROIMMUN Medizinische Labordiagnostika AG, HollisterStier Allergy by Jubilant Pharma Holdings Inc., HYCOR Biomedical, Indoor Biotechnologies, Inc., Laboratory Corporation of America Holdings., Lincoln Diagnostics, Inc., Medeca Pharma AB, Microbac Laboratories, Inc., Minaris Medical America, Inc., Neogen Corporatio, Nestlé Health Science, Omega Diagnostics Group PLC, Prota Therapeutics Pty. Ltd., Quest Consumer Inc., R-Biopharm AG, Romer Labs Division Holding GmbH, ROXALL Medizin GmbH, Siemens AG, STALLERGENES GREER International AG, Tecan Trading AG, and Thermo Fisher Scientific Inc..
This research report categorizes the Food Allergy Diagnostics & Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Product Type
- Diagnostic Tests Type
- In Vitro
- In Vivo/Skin
- Patch Test
- Skin Prick Test
- Therapeutic Treatment Type
- Antihistamines
- Epinephrine Auto-Injector
- Diagnostic Tests Type
- Technology
- Enzyme-Linked Immunosorbent Assay
- Polymerase Chain Reaction
- Source
- Eggs
- Fish
- Milk
- Peanuts
- Shellfish
- Soy
- Tree Nuts
- Wheat
- Component
- Consumables
- Instruments
- Services
- End-User
- Academic Research Institutes
- Diagnostics Laboratories
- Hospitals & Clinics
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
- Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
- Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
- Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
- Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
- Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.
- What is the current market size and projected growth?
- Which products, segments, applications, and regions offer promising investment opportunities?
- What are the prevailing technology trends and regulatory frameworks?
- What is the market share and positioning of the leading vendors?
- What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?
- Preface
- Research Methodology
- Executive Summary
- Market Overview
- Market Insights
- Food Allergy Diagnostics & Therapeutics Market, by Product Type
- Food Allergy Diagnostics & Therapeutics Market, by Technology
- Food Allergy Diagnostics & Therapeutics Market, by Source
- Food Allergy Diagnostics & Therapeutics Market, by Component
- Food Allergy Diagnostics & Therapeutics Market, by End-User
- Americas Food Allergy Diagnostics & Therapeutics Market
- Asia-Pacific Food Allergy Diagnostics & Therapeutics Market
- Europe, Middle East & Africa Food Allergy Diagnostics & Therapeutics Market
- Competitive Landscape
- Competitive Portfolio
- List of Figures [Total: 26]
- List of Tables [Total: 736]
- List of Companies Mentioned [Total: 34]
Diagnostic Tools for Food Allergies:
In the past, diagnosing food allergies required undergoing a series of tests, including skin tests and blood tests, and eliminating specific foods from the diet. However, today, various diagnostic tools are available that provide fast and accurate results. One of these tools is component-resolved diagnostics (CRD), which can identify which proteins in specific foods trigger allergic reactions. This technology provides precise information to healthcare professionals to help them determine the best course of treatment for their patients.
Food Allergy Therapeutics:
Food allergy therapeutics aim to prevent or reduce the severity of allergic reactions to specific foods. In recent years, multiple research studies have focused on immunotherapy, which involves exposing the patient to small amounts of the allergen to build up their body's tolerance. Sublingual immunotherapy (SLIT), a treatment that involves placing small amounts of the allergen under the tongue, has shown promising results in treating peanut allergies. Another therapy that has shown some success in trials is oral immunotherapy (OIT), which involves eating small amounts of the allergen with increasing doses gradually. While these treatments are still in the research stage, they offer hope for a safer future for those with food allergies.
Wearable Devices:
Wearable devices are increasingly being used in healthcare to monitor patient's conditions, and food allergy management is no exception. Some wearable devices can quickly detect allergens in the air, alerting the wearer before exposure occurs. These wristbands or patches can be particularly helpful for those with severe food allergies.
Smartphone Applications:
Smartphone applications can help track food allergens and ingredients in foods, reducing the risk of accidental exposure. Some applications use barcode scanning to identify food allergens or provide alerts for products that are flagged to contain allergens. Also, some applications can help people manage food allergies symptoms and provide guidance on nutrition and recipe planning.
Gene Therapy:
Gene therapy is a new approach to treating food allergies that involves engineering the patient's genes to produce protective proteins that replicate the allergen's immune response. This therapy has shown some promising results, though it's still in its early stages of development. If successfully developed, it could be a game-changer for those with food allergies as it may provide a permanent cure.
Technological advancements in food allergy diagnostics and therapeutics are changing the management of allergies, providing more accessible solutions, and offering hope for the future. These emerging technologies are helping to improve the quality of life for those with food allergies, reducing the risk of life-threatening reactions, and allowing people to lead fuller and more enjoyable lives. As these technologies develop and become more widespread, it's exciting to see what the future holds for food allergy management.
- How big is the Food Allergy Diagnostics & Therapeutics Market?
- What is the Food Allergy Diagnostics & Therapeutics Market growth?
- When do I get the report?
- In what format does this report get delivered to me?
- How long has 360iResearch been around?
- What if I have a question about your reports?
- Can I share this report with my team?
- Can I use your research in my presentation?